Zdrowie i gospodarka · 02/04/2003

FDA Announces Collection of Information for OMB Review

The Food and Drug Administration (FDA) is requesting public comment on the proposed collection of information related to the evaluation of long-term antibiotic therapy for individuals involved in anthrax remediation activities, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.